Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
about
Optimum duration of regimens for Helicobacter pylori eradicationMucin-Type O-Glycosylation in Gastric CarcinogenesisAntibiotic treatment for Helicobacter pylori: Is the end coming?Helicobacter pylori: Effect of coexisting diseases and update on treatment regimensComparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysisTreatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysisHelicobacter pylori infection in older peopleCurrent Helicobacter pylori treatment in 2014Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.Treatment of Helicobacter pylori infection: Where are we now?Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale."Concomitant" or "sequential" eradication of Helicobacter pylori: which regimen comes first?First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelinesUpdate on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy.Sequential therapy versus standard triple therapy in Helicobacter pylori eradication in a high clarithromycin resistance setting.Treatment of Helicobacter pylori infection: Past, present and futureSmall-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factorSeven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradicationPrimary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial.Effect of bacterial and host factors on Helicobacter pylori eradication therapyThe clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial.Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsiaHybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradicationThe Indications, Applications, and Risks of Proton Pump InhibitorsHigh-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study.Recurrent aphthous stomatitis and Helicobacter pylori.Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis.Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice.Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.Helicobacter pylori therapy: a paradigm shift.Sequential versus concomitant therapy for eradication of Helicobacter Pylori in patients with perforated duodenal ulcer: A randomized trialA 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experienceVonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind studyReview article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies.
P2860
Q24201841-B48A3C2A-F5A8-4C7D-8176-470E299DD621Q26740541-9FB28FE8-BB92-463A-8F0C-F4A44F3662D2Q26777623-04C54201-7D64-4ECE-8E8F-190CB3E519E7Q26777635-4C71269F-5EE5-40C4-8883-8CFA1E0514ACQ26796367-6882437E-BEAC-4E49-BE1D-529077D85F4FQ26799348-6FA597C8-7C40-4C99-A5C3-959A8DB49C59Q26853652-F3F47282-CD76-46F8-AC5C-9DDACC7B4944Q27000209-8428CA74-17D5-4416-AD4A-42B7C64AB084Q27322371-26BBE011-F8A2-4208-ABDD-B62826B9A5B1Q30251567-BEB76CC6-A3D4-44FE-AE39-0155D52207BAQ33698340-B98A69ED-063A-4BA7-B738-D75B9143BEE9Q33813453-3A85F130-6CA8-4FA1-8B4B-F08CD2DF906AQ33822948-2A20B479-05EF-476B-A28F-74270817A8B0Q33893567-B0A3CD5B-C05F-4CF3-BA96-352A02A04986Q34167285-1C0D8E97-0930-4167-A536-AB02EB327FE6Q34508830-E977011E-41F1-4929-BC82-1BF9ACD709F6Q34597864-3E3B7072-FFC2-41B3-9300-E4DDF106742CQ34932701-6A2D72D1-CA0D-4106-96B8-B699261856D2Q35152391-D4F2D154-C4B4-41EC-83CA-53ADCB03694EQ35598058-EF1569C3-00FF-440D-B2CA-13A2983DD318Q35614400-E03B9FEA-E308-4666-9066-8822E17A217AQ35738262-BFEE8FF0-A22D-4506-AEDF-B2FC51301965Q35794384-9BB8C030-C165-4E60-B35C-2F3E615A2AADQ35860594-3C28FF4C-634B-4F9C-8FBF-489AE58F3995Q35868940-B6D37FA3-1B02-4E47-9315-B319E2C50661Q36067627-C4CFDD63-E005-40D8-A285-5EB2386D6668Q36091187-9C88E9CB-E03F-47E6-8897-06F3F63A0B55Q36098476-68F498F3-752A-4D5A-A97F-05EE495B6BD4Q36678897-F0D755D9-B4BA-4F0D-8774-275EC696A434Q36909268-5F6B89C2-9A9A-47CD-B12D-A944799E5AFAQ36997005-DDF6EB13-3380-43AE-B6EA-3263B77233D5Q37066366-F1189A00-3B08-4865-8F8B-98AEBF70466EQ37082187-92EC6313-ECD8-476F-8A5A-38274BCADE29Q37189556-0FE35603-0E78-4E0B-8387-C00B819666E2Q37205675-019D3485-1A8B-4998-BB23-DD2A7244A47EQ37282589-EF5D4DF6-791C-4118-9B4E-46BD15A8EA0FQ37340339-5B117587-AC1D-4059-80F6-047A638FA479Q37378899-39056E29-B0F2-4BB4-A498-688AAA60DA01Q37398898-A325EBF7-7448-4EAF-9A9D-CFB5AA982C48Q37533456-0F25C97C-CC2C-48A0-BB73-2112FC075EBD
P2860
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Global eradication rates for H ...... analysis of sequential therapy
@ast
Global eradication rates for H ...... analysis of sequential therapy
@en
Global eradication rates for H ...... analysis of sequential therapy
@nl
type
label
Global eradication rates for H ...... analysis of sequential therapy
@ast
Global eradication rates for H ...... analysis of sequential therapy
@en
Global eradication rates for H ...... analysis of sequential therapy
@nl
prefLabel
Global eradication rates for H ...... analysis of sequential therapy
@ast
Global eradication rates for H ...... analysis of sequential therapy
@en
Global eradication rates for H ...... analysis of sequential therapy
@nl
P2093
P2860
P31
P921
P3181
P356
P1433
P1476
Global eradication rates for H ...... analysis of sequential therapy
@en
P2093
Carmelo Scarpignato
Dino Vaira
Nimish Vakil
P2860
P3181
P356
10.1136/BMJ.F4587
P407
P433
P50
P5008
P577
2013-08-07T00:00:00Z